References
- 1. Carter CM, Metcalfe DD. Biology of mast cells and the mastocytosis syndromes. In: Wolff K, Lowel A, Stephen I, Gilchrest BA, Paller AS, Leffel DJ, editors. Fitzpatrick’s Dermatology in general medicine. 7th ed. New York: Mc Graw Hill; 2008. p. 1435-43.
- 2. Prćić S, Đuran V, Gajinov Z, Čeke M, Tomić J, Vijatov G, et al. Nodular mastocytosis of the vulva and coexisting urticaria pigmentosa. Serb J Dermatol Venereol 2009;1(4):153-6.
- 3. Chan JK. Tumors of the lymphoreticular system. In: Flecher CD, editor. Diagnostic histopathology of tumors. 3rd ed. Edinburgh: Churchill Livingstone Elsevier; 2007. p. 1139-289.
- 4. Valent P, Horny HP, Li CY, Longley BJ, Metcalfe DD, Parwaresch RM, et al. Mastocytosis. In: Jaffe ES, Lee Harris N, Stein H, Vardiman JW, editors. Pathology and genetics of tumours of haematopoetic and lymphoid tissues. Oxford: Oxford University Press; 2001. p. 291-304.
- 5. Flaquel B. Cutaneous mastocytosis. Rev Prat 2006;56(16):1745-51.
- 6. Akoglu G, Erkin G, Cakir B, Boztepe G, Sahin S, Karaduman A, et al. Cutaneous mastocytosis: demographic aspects and clinical features of 55 patients. J Eur Acad Dermatol Venereol 2006;20(8):969-73.
- 7. Ben-Amitai D, Metzker A, Cohen HA. Pediatric cutaneous mastocytosis: a review of 180 patients. Isr Med Assoc J 2005;7(5):320-2.
- 8. Merante S, Chichino G, Boveri E, Gottardi E, Soverini S, Cilloni D, et al. First case an AIDS patient with systemic mast cell disease associated with eosinophilia FIP1-positive treated with Immatinab mesylate therapy. J Clin Oncol 2006;24(4):e6-e7.
- 9. Soilleux EJ, Grills C, Cooper SM. Cutaneous mastocytosis in human immunodeficiency virus: an unfortunate coincidence? Clin Exp Dermatol 2008;33:619-21.
- 10. Escribano L, Alvarez-Twose I, Sanches-Munoz L, Montero AG, Nuriez R, Almeida J, et al. Prognosis in adult indolent systemic mastocytosis: a long term study of the Spanish network on mastocytosis in a series of 145 patients. J Allergy Clin Immunol 2009;124(3):514-21.
- 11. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001;25(7):603-25.
- 12. Akin C, Valent P, Escribano L. Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment. Curr Allergy Asthma Rep 2006;6:282-8.
- 13. Marone G, Florio G, Petraroli A, Triggiani M, de Paulis A. Human mast cells and basophils in HIV-1 infection. Trends Immunol 2001;22(5):229-32.
- 14. de Paulis A, Florio G, Prevete N, et al. HIV-1 envelope gp41 peptides promote migration of human Fc epsilon RI+ cells and inhibit IL-13 synthesis through interaction with formyl peptide receptors. J Immunol 2002;169:4559-67.
- 15. Li Y, Li L, Wadley R, et al. Mast cells/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5, and CXCR4. Blood 2001;97:3484-90.
- 16. Nelson AM, Auerbach A, Man YG. Failure to detect active virus replication in mast cells at various tissue sites of HIV patients by immunohistochemistry. Int J Biol Sci 2009;5(6):603-10.
- 17. Sundstrom JB, Ellis JE, Hair GA, Kirshenbaum AS, Metcalfe DD, Yi H, et al. Human tissue mast cells are an inducible cellular reservoir of persistent HIV infection. Blood;2007:109(12):5293-300.